Page last updated: 2024-10-22

albuterol and Briquet Syndrome

albuterol has been researched along with Briquet Syndrome in 2 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choy, AC1
Patterson, R2
Patterson, DR1
Grammer, LC1
Greenberger, PA1
McGrath, KG1
Harris, KE1
Lieberman, P1

Reviews

1 review available for albuterol and Briquet Syndrome

ArticleYear
Idiopathic anaphylaxis: a purely internal reaction.
    Hospital practice (1995), 1996, Jul-15, Volume: 31, Issue:7

    Topics: Albuterol; Anaphylaxis; Exercise; Food; Glucocorticoids; Histamine H1 Antagonists; Humans; Hydroxyzi

1996

Other Studies

1 other study available for albuterol and Briquet Syndrome

ArticleYear
Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis.
    The Journal of allergy and clinical immunology, 1995, Volume: 96, Issue:6 Pt 1

    Topics: Adult; Albuterol; Anaphylaxis; Diagnosis, Differential; Female; Humans; Hydroxyzine; Hypersensitivit

1995